Gut Microbiome-Centered Therapies for Alcohol-Associated Liver Disease
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gut Microbiome-Centered Therapies for Alcohol-Associated Liver Disease
Authors
Keywords
-
Journal
SEMINARS IN LIVER DISEASE
Volume 43, Issue 03, Pages 311-322
Publisher
Georg Thieme Verlag KG
Online
2023-08-02
DOI
10.1055/a-2145-7331
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Engineered bacteria producing aryl‐hydrocarbon receptor agonists protect against ethanol‐induced liver disease in mice
- (2023) Tetsuya Kouno et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- The Beneficial Effects of Lactobacillus GG Therapy on Liver and Drinking Assessments in Patients with Moderate Alcohol-Associated Hepatitis
- (2023) Vatsalya Vatsalya et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Effect of Prophylactic Antibiotics on Mortality in Severe Alcohol-Related Hepatitis
- (2023) Alexandre Louvet et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The gut–liver axis and gut microbiota in health and liver disease
- (2023) Cynthia L. Hsu et al. NATURE REVIEWS MICROBIOLOGY
- Long-term Outcomes of Stool Transplant in Alcohol-associated Hepatitis—Analysis of Clinical Outcomes, Relapse, Gut Microbiota and Comparisons with Standard Care
- (2022) Cyriac A. Philips et al. Journal of Clinical and Experimental Hepatology
- Fecal microbiota transplantation in alcohol-associated acute-on-chronic liver failure: an open-label clinical trial
- (2022) Anima Sharma et al. Hepatology International
- Effect of rifaximin on infections, acute‐on‐chronic liver failure and mortality in alcoholic hepatitis: A pilot study (RIFA‐AH)
- (2022) César Jiménez et al. LIVER INTERNATIONAL
- The impact of rifaximin on inflammation and metabolism in alcoholic hepatitis: A randomized clinical trial
- (2022) Nina Kimer et al. PLoS One
- Dosing of Rifaximin Soluble Solid Dispersion Tablets in Adults With Cirrhosis: 2 Randomized, Placebo-controlled Trials
- (2022) Jasmohan S. Bajaj et al. Clinical Gastroenterology and Hepatology
- Fecal microbiota transplantation compared with prednisolone in severe alcoholic hepatitis patients: a randomized trial
- (2022) Apurva Pande et al. Hepatology International
- Alcohol-Associated Hepatitis
- (2022) Ramon Bataller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Lactobacillus casei on lipid metabolism and intestinal microflora in patients with alcoholic liver injury
- (2021) Xuelong Li et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- CRIg on liver macrophages clears pathobionts and protects against alcoholic liver disease
- (2021) Yi Duan et al. Nature Communications
- A Randomized Clinical Trial of Fecal Microbiota Transplant for Alcohol Use Disorder
- (2020) Jasmohan S Bajaj et al. HEPATOLOGY
- A Double-Blind, Randomized Placebo-Controlled Trial of Probiotic Lactobacillus casei Shirota in Stable Cirrhotic Patients
- (2020) Jane Macnaughtan et al. Nutrients
- Changes in the fecal bacterial microbiota associated with disease severity in alcoholic hepatitis patients
- (2020) Sonja Lang et al. Gut Microbes
- National Trends and Long-term Outcomes of Liver Transplant for Alcohol-Associated Liver Disease in the United States
- (2019) Brian P. Lee et al. JAMA Internal Medicine
- Microbiome as a therapeutic target in alcohol-related liver disease
- (2019) Shiv K. Sarin et al. JOURNAL OF HEPATOLOGY
- Fecal Microbial Transplant Capsules are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo‐Controlled Trial
- (2019) Jasmohan S Bajaj et al. HEPATOLOGY
- Intestinal fungal dysbiosis and systemic immune response to fungi in patients with alcoholic hepatitis
- (2019) Sonja Lang et al. HEPATOLOGY
- The Candida albicans exotoxin candidalysin promotes alcohol-associated liver disease
- (2019) Huikuan Chu et al. JOURNAL OF HEPATOLOGY
- Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease
- (2019) Yi Duan et al. NATURE
- Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
- (2019) Zachariah DeFilipp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo—a Meta-analysis of Individual Data
- (2018) Alexandre Louvet et al. GASTROENTEROLOGY
- Alcohol Use in Patients with Chronic Liver Disease
- (2018) Daniel Fuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice
- (2018) Tim Hendrikx et al. GUT
- Alcohol-Associated Cirrhosis
- (2018) Michael R. Lucey Clinics in Liver Disease
- Recovery of ethanol-inducedAkkermansia muciniphiladepletion ameliorates alcoholic liver disease
- (2017) Christoph Grander et al. GUT
- Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial
- (2017) Jasmohan S. Bajaj et al. HEPATOLOGY
- Rifaximin has minor effects on bacterial composition, inflammation, and bacterial translocation in cirrhosis: A randomized trial
- (2017) Nina Kimer et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Intestinal REG3 Lectins Protect against Alcoholic Steatohepatitis by Reducing Mucosa-Associated Microbiota and Preventing Bacterial Translocation
- (2016) Lirui Wang et al. Cell Host & Microbe
- Pathogenesis of alcoholic liver disease
- (2016) Kazushi Sugimoto et al. HEPATOLOGY RESEARCH
- Bidirectional Communication between Liver and Gut during Alcoholic Liver Disease
- (2016) Peter Stärkel et al. SEMINARS IN LIVER DISEASE
- Rifaximin Exerts Beneficial Effects Independent of its Ability to Alter Microbiota Composition
- (2016) Dae J Kang et al. Clinical and Translational Gastroenterology
- Acute-on-chronic liver failure in cirrhosis
- (2016) Vicente Arroyo et al. Nature Reviews Disease Primers
- Effects of probiotics (cultured Lactobacillus subtilis/Streptococcus faecium) in the treatment of alcoholic hepatitis
- (2015) Sang Hak Han et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- The intestinal microbiota: its role in health and disease
- (2015) Luc Biedermann et al. EUROPEAN JOURNAL OF PEDIATRICS
- Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease
- (2015) M Llopis et al. GUT
- Short- or long-term high-fat diet feeding plus acute ethanol binge synergistically induce acute liver injury in mice: An important role for CXCL1
- (2015) Binxia Chang et al. HEPATOLOGY
- Alcohol Induced Alterations to the Human Fecal VOC Metabolome
- (2015) Robin D. Couch et al. PLoS One
- Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?
- (2015) Katharina Brandl et al. Expert Review of Gastroenterology & Hepatology
- Rifaximin improves thrombocytopenia in patients with alcoholic cirrhosis in association with reduction of endotoxaemia
- (2015) Georgios N. Kalambokis et al. LIVER INTERNATIONAL
- Burden of Disease Associated with Alcohol Use Disorders in the United States
- (2014) Jürgen Rehm et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity
- (2014) Sophie Leclercq et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Global burden of alcoholic liver diseases
- (2013) Jürgen Rehm et al. JOURNAL OF HEPATOLOGY
- Pathological bacterial translocation in liver cirrhosis
- (2013) Reiner Wiest et al. JOURNAL OF HEPATOLOGY
- Altered profile of human gut microbiome is associated with cirrhosis and its complications
- (2013) Jasmohan S. Bajaj et al. JOURNAL OF HEPATOLOGY
- Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy
- (2013) Jasmohan S. Bajaj et al. PLoS One
- Rifaximin Improves Systemic Hemodynamics and Renal Function in Patients With Alcohol-Related Cirrhosis and Ascites
- (2012) Georgios N. Kalambokis et al. Clinical Gastroenterology and Hepatology
- Alcohol Metabolism
- (2012) Arthur I. Cederbaum Clinics in Liver Disease
- Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis
- (2012) Jiannis Vlachogiannakos et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study
- (2011) Javier Fernández et al. HEPATOLOGY
- Probiotics in hepatology
- (2011) Jan Lata WORLD JOURNAL OF GASTROENTEROLOGY
- Rifaximin Treatment in Hepatic Encephalopathy
- (2010) Nathan M. Bass et al. NEW ENGLAND JOURNAL OF MEDICINE
- Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study
- (2008) Irina A. Kirpich et al. ALCOHOL
- Microbes in Gastrointestinal Health and Disease
- (2008) Andrew S. Neish GASTROENTEROLOGY
- Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis
- (2008) Vanessa Stadlbauer et al. JOURNAL OF HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started